Journal Information
Vol. 106. Issue 9.
Pages 759 (November 2015)
Vol. 106. Issue 9.
Pages 759 (November 2015)
Images in Dermatology
Full text access
Treatment of Harlequin Ichthyosis With Acitretin
Ictiosis arlequín tratada con acitretino
Visits
25024
C. Arjona-Aguilera
Corresponding author
cintiaarjona@hotmail.com

Corresponding author.
, C. Albarrán-Planelles, D. Jiménez-Gallo
Servicio de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Puerta del Mar, Cádiz, Spain
This item has received
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

Harlequin ichthyosis is the most severe autosomal recessive congenital ichthyosis caused by homozygotic mutations of the ABCA12 gene. About 200 cases have been published. We present the case of a premature newborn infant with typical characteristics of harlequin ichthyosis: thick yellowish-brown scales with deep fissures affecting the whole body surface, hypoplasia of all 20 digits, digital contractures, eclabium, ectropion, and madarosis (Fig. 1A). Skin biopsy taken from the trunk revealed a thick and compact orthokeratosis that extended up to dilated pilosebaceous units. Systemic treatment with acitretin was started on the ninth day of life at a dose of 0.5mg/kg/d, increased to 1mg/kg/d after 2 months. Tolerance and the clinical response were excellent (Fig. 1B). The infant presented progressive desquamation, with improvement of the ectropion, eclabium, and digital contractures, and was discharged from hospital at 8 months (Fig. 1, C and D). The systemic retinoids are associated with increased survival to 2 to 20 years of age. Acitretin is the drug of choice because of its shorter plasma half-life, which reduces side effects. Prior to its introduction, mortality was around 70% in the first weeks of life. However, it is difficult to carry out clinical efficacy trials because of the very low prevalence of harlequin ichthyosis and because neonatal intensive care (fluid and electrolyte support, topical emollients and keratolytic agents, debridement of constricting bands, monitoring for infection) is also crucial to the prognosis.

Figure 1
(0.41MB).

Please cite this article as: Arjona-Aguilera C, Albarrán-Planelles C, Jiménez-Gallo D. Ictiosis arlequín tratada con acitretino. Actas Dermosifiliogr. 2015;106:759.

Copyright © 2015. Elsevier España, S.L.U. and AEDV
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?